_:n5c649d8b18124f39972d522321a9b5ffxb6
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/SearchAction>
<https://www.empr.com/home/news/drugs-in-the-pipeline/voxelotor-gets-priority-review-for-pediatric-sickle-cell-disease/>